Adiponectin levels during low- and high-fat eucaloric diets in lean and obese women

Obesity Research

Volumn 13, Issue 9, 2005, Pages 1566-1571

  Berk, Evan S ^b   Kovera, Albert J ^a   Boozer, Carol N ^a,b   Pi Sunyer, F X ^a,b   Johnson, Julia A ^a   Albu, Jeanine B ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adiponectin; Insulin resistance; Macronutrient manipulated diets

Indexed keywords

ADIPONECTIN; FATTY ACID; INSULIN; LEPTIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BODY WEIGHT; CALORIMETRY; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHYSIOLOGY;

ADIPONECTIN; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CALORIMETRY; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MAGNETIC RESONANCE IMAGING; OBESITY; THINNESS;

EID: 33644673827     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.192     Document Type: Article

References (26)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Kaplan JP. The continuing epidemic of obesity and diabetes in the United States. JAMA. 2001;286:1195-200.
2. Maeda K, Okubo K, Shimomuta I, Funahashi T, Matsuzava Y, Matsubuza K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose most abundant gene transcript 1). Biochem Biophys Res Comm. 1996;221:286-9.
3. Diez J, Iglesias M. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endo. 2003: 148:293-300.
4. Yamauachi T, Koman J, Waki H, et al. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-6.
5. Arita Y, Kihora S, Ouchi N, et al. Paradoxical decrease of adipose specific protein, adiponectin in obesity. Biochem Biophys Rex Commun. 1999;257:79-83.
6. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-5.
7. Berg AH, Combs IP, Du X, Brownlee M, Scherer P. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947-53.
8. Maeda N, Shimomura I, Kishida K, et al. Diet induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;7:731-7.
9. Ross R. Magnetic resonance imaging provides new insights into the characterization of adipose and lean tissue distribution. Can J Clin Pharmacol. 1996;74:778-85.
10. Bergman R, Beard J, Chen M. The minimal modeling method: assessment of insulin sensitivity and B-Cell function in vivo. In: Larner J. Pohl S. eds. Methods in Clinical Diabetes Research. New York: Wiley International; 1986. pp 13-20.
11. Haffner SM, D'Agostino R Jr., Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. Diabetes. 1996;45:742-8.
12. Albu J, Shur M, Curi M, Murphy L, Heymsfield, Pi-Sunyer FX. Resting metabolic rate in obese, pre-menopausal black women. Am J Clin Nutr. 1997;66:531-8.
13. Zhang K, Sun M, Werner P, et al. Sleeping metabolic rate in relation to body mass index and body composition. Intl J Obesity. 2002;26:376-83.
14. Shand B, Scott R, Elder P, George P. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab. 2003;5:349-53.
15. Abbasi F, Chu J, Lamendola C, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes. 2004;53:585-90.
16. Fruebis J, Tsao T, Javorsci S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases tatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001;98:2005-10.
17. Shklyaev S, Aslanidi G, Tennant M, et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Nutl Acad Sci USA. 2003;100:14217-22.
18. Yannakoulia M, Yiannakouris N, Bluher S, Matalas A, Klumis Z, Montzeris C. Body fat mass and macronutrient intake in relation to circulation soluble leptin receptor. free leptin index, adiponectin and resistin concentrations in healthy humans. J Clin Endo & Metab. 2003;88:1730-6.
19. Esposito K, Nappo F, Giugliano F, Masella M, Mafella K, Guigliano D. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2003; 78:1135-40.
20. Peake P. Krikeots A, Denyer G, Campbell L, Charles worth J. The postprandial response of adiponectin to a highfat meal in normal and insulin-resistant subjects. Intl J Obesity. 2003;27:657-62.
21. Thamer C, Haap M, Bachmann O, et al. Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans. Diabetologia. 2004;47:1303-5.
22. Boden G, Sargard K, Homko C, Mozzoli M, Stein P. Effect of a low-carbohydrate diet on appetite, blood glucose levels and insulin resistance in obese patients with type 2 diabetes. Ann Int Med. 2005;142:403-11.
23. Bernstein E, Koutikia P, Ljungquist K, Brev J, CanavanB, Grinspoon S. Acute regulation of adiponectin by free fatty acids. Metabolism. 2004;53:790-3.
24. Möhlig M, Wegewitz U, Osterhoff M, et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res. 2002;34:665-8.
25. Mead J, Irvine S, Ramji D. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med. 2002;80: 753-9.
26. von Eynattien M, Schneider J, Humpert P et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia. Diabetes Care. 2004;12:2925-9.